885278-30-8

Basic information

• Product Name: 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE
• Synonyms: 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE;1H-Indazole-3-carbonitrile, 6-chloro-;Methyl 5-((2-Ethoxy-2-Oxoethyl)Amino)-2-Fluorobenzoate(WXC02807)
• CAS NO: 885278-30-8
• Molecular Formula: C8H4ClN3
• Molecular Weight: 177.59
• EINECS: 604-604-1
• Mol File: 885278-30-8.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 403.0±25.0 °C(Predicted)
• Appearance: /
• Density: 1.50
• Storage Temp.: 2-8°C
• PKA: 9.69±0.40(Predicted)
• CAS DataBase Reference: 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE(885278-30-8)
• EPA Substance Registry System: 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE(885278-30-8)

Safety Data

• Hazardous Substances Data: 885278-30-8(Hazardous Substances Data)

Usage

General Description

6-CHLORO-1H-INDAZOLE-3-CARBONITRILE is a chemical compound consisting of a chloro-substituted indazole ring with a cyano group at the 3-position. It is a heterocyclic organic compound that is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its molecular structure and functional groups make it a versatile building block for the production of a wide range of chemical derivatives. 6-CHLORO-1H-INDAZOLE-3-CARBONITRILE has potential applications in the development of new drugs and materials due to its unique chemical properties and reactivity. Its synthesis and study are of interest to researchers in the fields of organic chemistry, medicinal chemistry, and chemical engineering.

Upstream product

• 557-21-1 zinc(II) cyanide 
• 503045-59-8 6-chloro-3-iodo-1H-indazole 
• 95-79-4 5-chloro-2-methyl-benzenamine 
• 61072-56-8 4-chloro-2-fluorobenzaldehyde 
• 698-25-9 6-chloro-1H-indazole 

Downstream Products

• 1350852-88-8 4-amino-2-[6-chloro-1-(3,3,4,4,4-pentafluorobutyl)-1H-indazol-3-yl]-5-methyl-5-phenyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one 
• 1350854-36-2 2-[6-chloro-1-(3,3,4,4,4-pentafluorobutyl)-1H-indazol-3-yl]-5-methyl-4-(methylamino)-5-phenyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one 
• 1350856-26-6 4-bromo-2-[6-chloro-1-(3,3,4,4,4-pentafluorobutyl)-1H-indazol-3-yl]-5-methyl-5-phenyl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one 
• 1447733-50-7 6-chloro-1-(2-fluorobenzyl)-1H-indazole-3-carboximidamide acetate 
• 1447733-51-8 6-chloro-1-(2-fluorobenzyl)-1H-indazole-3-carboximidohydrazide 
• 1447733-52-9 methyl 2-{3-[6-chloro-1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-hydroxy-1,2,4-triazin-6-yl}-2-methylpropanoate 
• 1447733-43-8 3-[6-chloro-1-(2-fluorobenzyl)-1H-indazol-3-yl]-7,7-dimethyl-5,7-dihydro-6H-pyrrolo[2,3-e][1,2,4]triazin-6-one 
• 1447733-60-9 methyl 2-{5-chloro-3-[6-chloro-1-(2-fluorobenzyl)-1H-indazol-3-yl]-1,2,4-triazin-6-yl}-2-methylpropanoate 
• 1447733-48-3 6-chloro-1-(2-fluorobenzyl)-1H-indazole-3-carbonitrile 

Relevant articles and documents

SOLUBLE GUANYLATE CYCLASE STIMULATORS

The invention provides compounds of the Formula (I) or a pharmaceutically acceptable salts thereof, wherein X, Y, Z, R1, R2, R4, Ra, and the subscripts m, p, and q are as described herein. The compounds or their